These tools may help your patients get their medications at reduced or no cost* and help them access support from our patient support team.
Novartis Oncology shares your commitment to helping patients living with cancer receive the medicines they need. Patient Assistance Now Oncology (PANO) offers quick and easy access to information about our wide range of resources available to your patients.
Our patient support counselors speak 160 languages. We'll work with you to help your patients get the medicine they need quickly, easily, and for less money.*
*The hotline and Novartis Pharmaceuticals Corporation do not guarantee success in obtaining reimbursement, nor do we submit appeals on behalf of providers or patients. Third-party payment for medical products and services is affected by numerous factors, not all of which can be anticipated or resolved by hotline staff.
Visit a single site to find co-pay assistance for eligible patients for most Novartis Oncology medications.
Patients can find out if they are eligible by calling our hotline: 1-877-577-7756 or visiting www.copay.novartisoncology.com
Limitations apply. Offer is not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice.
The Novartis Patient Assistance Foundation, Inc., is committed to providing access to our medicines for those most in need. If you are experiencing financial hardship and have no third-party insurance coverage for your medicines, you may be eligible to receive your Novartis medicines at no cost.
Please be advised that access to the medicines distributed through the Novartis Patient Assistance Foundation, Inc, is free of charge to all eligible patients. Novartis is not affiliated with any individual or organization that may charge patients a fee(s) to assist them in completing applications for our program. These individuals or organizations are acting independently of the Novartis Patient Assistance Foundation, Inc., and its affiliates and do not have Novartis' consent.